Your browser is no longer supported. Please, upgrade your browser.
NDRA ENDRA Life Sciences Inc. daily Stock Chart
ENDRA Life Sciences Inc.
Index- P/E- EPS (ttm)-2.23 Insider Own8.10% Shs Outstand14.50M Perf Week-3.33%
Market Cap12.51M Forward P/E- EPS next Y-1.24 Insider Trans0.00% Shs Float12.68M Perf Month-4.36%
Income-18.10M PEG- EPS next Q-0.27 Inst Own8.70% Short Float4.89% Perf Quarter40.75%
Sales- P/S- EPS this Y-7.50% Inst Trans23.32% Short Ratio1.86 Perf Half Y-52.68%
Book/sh0.22 P/B4.09 EPS next Y-5.10% ROA-393.90% Target Price- Perf Year-42.00%
Cash/sh0.22 P/C4.04 EPS next 5Y- ROE-688.90% 52W Range0.60 - 2.25 Perf YTD-46.49%
Dividend- P/FCF- EPS past 5Y-31.30% ROI- 52W High-60.04% Beta-
Dividend %- Quick Ratio2.30 Sales past 5Y- Gross Margin- 52W Low50.08% ATR0.12
Employees15 Current Ratio2.40 Sales Q/Q- Oper. Margin- RSI (14)46.62 Volatility14.86% 12.98%
OptionableNo Debt/Eq0.00 EPS Q/Q22.00% Profit Margin- Rel Volume12.72 Prev Close0.93
ShortableYes LT Debt/Eq0.00 EarningsMar 26 AMC Payout- Avg Volume333.91K Price0.90
Recom2.00 SMA20-7.39% SMA505.50% SMA200-17.22% Volume4,247,629 Change-3.32%
Jun-30-20 08:12AM  
Jun-23-20 08:15AM  
Jun-08-20 04:00PM  
Jun-03-20 09:00AM  
May-14-20 04:00PM  
May-06-20 08:00AM  
May-01-20 08:00AM  
Apr-30-20 08:00AM  
Apr-13-20 04:05PM  
Mar-26-20 04:05PM  
Mar-19-20 08:15AM  
Mar-17-20 08:30AM  
Mar-11-20 10:20AM  
Mar-10-20 08:00AM  
Mar-09-20 08:00AM  
Mar-06-20 09:10AM  
Mar-03-20 08:00AM  
Jan-15-20 09:00AM  
Dec-19-19 08:30AM  
Dec-11-19 05:30PM  
Nov-13-19 04:01PM  
Nov-05-19 08:30AM  
Nov-04-19 08:00AM  
Oct-28-19 03:41PM  
Oct-14-19 08:30AM  
Sep-26-19 08:30AM  
Sep-10-19 08:31AM  
Aug-21-19 08:31AM  
Aug-08-19 04:01PM  
Jul-29-19 08:31AM  
Jul-22-19 08:31AM  
Jul-04-19 11:45AM  
Jul-01-19 08:31AM  
Jun-24-19 08:31AM  
Jun-03-19 08:31AM  
May-14-19 04:01PM  
Apr-24-19 08:31AM  
Apr-17-19 08:31AM  
Apr-03-19 08:31AM  
Mar-29-19 08:31AM  
Mar-11-19 04:01PM  
Feb-22-19 08:31AM  
Jan-22-19 08:31AM  
Jan-02-19 07:31AM  
Dec-17-18 07:31AM  
Dec-03-18 01:00PM  
Nov-26-18 07:31AM  
Nov-14-18 08:10AM  
Nov-13-18 03:01PM  
Nov-08-18 07:31AM  
Nov-07-18 03:01PM  
Nov-05-18 03:01PM  
Oct-29-18 10:44AM  
Oct-24-18 08:31AM  
Oct-23-18 08:31AM  
Oct-16-18 08:31AM  
Oct-15-18 04:01PM  
Oct-11-18 08:50AM  
Oct-10-18 04:10PM  
Aug-29-18 08:31AM  
Aug-13-18 04:01PM  
Jul-31-18 08:31AM  
Jul-25-18 08:31AM  
Jul-12-18 08:31AM  
Jul-02-18 08:31AM  
Jun-05-18 08:30AM  
May-24-18 04:19PM  
May-15-18 04:01PM  
Apr-26-18 08:31AM  
Apr-09-18 08:31AM  
Apr-02-18 10:30AM  
Mar-20-18 04:01PM  
Mar-08-18 12:59PM  
Mar-07-18 08:31AM  
Feb-27-18 08:31AM  
Feb-15-18 08:31AM  
Feb-05-18 08:31AM  
Dec-27-17 05:25PM  
Dec-08-17 06:33PM  
Nov-30-17 03:45PM  
Nov-22-17 08:31AM  
Nov-15-17 08:31AM  
Nov-08-17 09:22AM  
Nov-02-17 08:31AM  
Oct-23-17 08:31AM  
Sep-28-17 08:31AM  
Sep-27-17 08:31AM  
Sep-07-17 08:31AM  
Sep-06-17 08:31AM  
Aug-08-17 08:31AM  
Jul-06-17 10:00AM  
ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound. It offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. It also offers Nexus-128 system that combines light-based thermos-acoustics and ultrasound to address the imaging needs of researchers studying disease models in pre-clinical applications. ENDRA Life Sciences Inc. has collaborative research agreement with General Electric Company. The company was incorporated in 2007 and is based in Ann Arbor, Michigan.